JAGX vs. HOOK, RLYB, TPST, SCYX, ASMB, VTVT, MRNS, IFRX, SLS, and MNOV
Should you be buying Jaguar Health stock or one of its competitors? The main competitors of Jaguar Health include Hookipa Pharma (HOOK), Rallybio (RLYB), Tempest Therapeutics (TPST), SCYNEXIS (SCYX), Assembly Biosciences (ASMB), vTv Therapeutics (VTVT), Marinus Pharmaceuticals (MRNS), InflaRx (IFRX), SELLAS Life Sciences Group (SLS), and MediciNova (MNOV). These companies are all part of the "pharmaceutical preparations" industry.
Hookipa Pharma (NASDAQ:HOOK) and Jaguar Health (NASDAQ:JAGX) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, institutional ownership, community ranking, valuation, analyst recommendations, media sentiment, risk, earnings and profitability.
63.9% of Hookipa Pharma shares are held by institutional investors. Comparatively, 12.0% of Jaguar Health shares are held by institutional investors. 5.8% of Hookipa Pharma shares are held by company insiders. Comparatively, 0.2% of Jaguar Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Hookipa Pharma presently has a consensus target price of $4.67, suggesting a potential upside of 472.32%. Given Jaguar Health's higher possible upside, analysts plainly believe Hookipa Pharma is more favorable than Jaguar Health.
Jaguar Health received 1750 more outperform votes than Hookipa Pharma when rated by MarketBeat users. Likewise, 89.08% of users gave Jaguar Health an outperform vote while only 69.11% of users gave Hookipa Pharma an outperform vote.
Hookipa Pharma has a beta of 0.92, indicating that its stock price is 8% less volatile than the S&P 500. Comparatively, Jaguar Health has a beta of 0.89, indicating that its stock price is 11% less volatile than the S&P 500.
Jaguar Health has lower revenue, but higher earnings than Hookipa Pharma.
In the previous week, Jaguar Health had 5 more articles in the media than Hookipa Pharma. MarketBeat recorded 8 mentions for Jaguar Health and 3 mentions for Hookipa Pharma. Jaguar Health's average media sentiment score of 0.59 beat Hookipa Pharma's score of 0.14 indicating that Hookipa Pharma is being referred to more favorably in the media.
Hookipa Pharma has a net margin of -88.73% compared to Hookipa Pharma's net margin of -377.95%. Jaguar Health's return on equity of -33.33% beat Hookipa Pharma's return on equity.
Summary
Hookipa Pharma beats Jaguar Health on 10 of the 15 factors compared between the two stocks.
Get Jaguar Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for JAGX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding JAGX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartThis chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Jaguar Health Competitors List
Related Companies and Tools